Informations techniques
Exploitant
ARROW GENERIQUES
Présentation
TERBUTALINE ARROW 5 mg/2 ml, solution pour inhalation par nébuliseur en récipient unidose
Boîte de 50 récipients unidoses de 2 ml (code CIP: 365 790-1)
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
mwKw3SJ5pjGQfaut